From major journals, first or last author from the Institute for Cancer Research
Juvkam IS, Zlygosteva O, Sitarz M, Thiede B, Sørensen BS, Malinen E, Edin NJ, Søland TM, Galtung HK(2023) Proton Compared to X-Irradiation Induces Different Protein Profiles in Oral Cancer Cells and Their Derived Extracellular Vesicles Int J Mol Sci, 24(23) DOI 10.3390/ijms242316983, PubMed 38069306
Ayuda-Durán P, Hermansen JU, Giliberto M, Yin Y, Hanes R, Gordon S, Kuusanmäki H, Brodersen AM, Andersen AN, Taskén K, Wennerberg K, Enserink JM, Skånland SS(2023) Standardized assays to monitor drug sensitivity in hematologic cancers Cell Death Discov, 9(1), 435 DOI 10.1038/s41420-023-01722-5, PubMed 38040674
Chen Y, He L, Ianevski A, Ayuda-Durán P, Potdar S, Saarela J, Miettinen JJ, Kytölä S, Miettinen S, Manninen M, Heckman CA, Enserink JM, Wennerberg K, Aittokallio T(2023) Robust scoring of selective drug responses for patient-tailored therapy selection Nat Protoc(in press) DOI 10.1038/s41596-023-00903-x, PubMed 37996540
Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, Rustad EH, Meyer S, Isaksen K, Chellappa S, Kushekhar K, Beiske K, Førsund MS, Spetalen S, Holte H, Østenstad B, Brodtkorb M, Kimby E, Olweus J, Taskén K, Newman AM, Lorenz S, Smeland EB, Alizadeh AA, Huse Ket al.(2023) Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma Blood Adv, 7(23), 7216-7230 DOI 10.1182/bloodadvances.2023010158, PubMed 37695745
Fein JA, Shouval R, Krieger E, Spellman SR, Wang T, Baldauf H, Fleischhauer K, Kröger N, Horowitz MM, Maiers M, Miller JS, Mohty M, Nagler A, Weisdorf DJ, Malmberg KJ, Toor AA, Schetelig J, Romee R, Koreth J(2023) Systematic Evaluation of Donor-KIR/Recipient-HLA Interactions in HLA-matched Hematopoietic Cell Transplantation for AML Blood Adv(in press) DOI 10.1182/bloodadvances.2023011622, PubMed 38052043
Andersen AN, Brodersen AM, Ayuda-Durán P, Piechaczyk L, Tadele DS, Baken L, Fredriksen J, Stoksflod M, Lenartova A, Fløisand Y, Skånland SS, Enserink JM(2023) Clinical forecasting of acute myeloid leukemia using ex vivo drug-sensitivity profiling Cell Rep Methods, 100654(in press) DOI 10.1016/j.crmeth.2023.100654, PubMed 38065095